4TEEN4 Pharmaceuticals GmbH is developing a novel approach for the diagnosis and treatment of a recently discovered disease mechanism directly linked to acute organ failure, caused by a circulating enzyme in the blood (DPP3). Procizumab is a humanized therapeutic antibody currently in clinical development at 4TEEN4. Additionally, 4TEEN4 is developing diagnostic tests for the detection of severe systemic diseases associated with DPP3.
To strengthen our team, we are looking for a Clinical Trial Assistant (m/f/d) to join us as soon as possible in a permanent full-time position (part-time possible).
APCT1_DE